Explore more publications!
Health Industry Watch
Got News to Share?

Press Releases

Global MedTech and Healthcare IT Industry: Accelerating Digital Transformation in Patient Care
January 9, 2026

Global MedTech and Healthcare IT Industry: Accelerating Digital Transformation in Patient Care

Indeterminate GlobeNewswire, Inc.
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
January 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire, Inc.
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
January 9, 2026

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

Indeterminate GlobeNewswire, Inc.
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
January 9, 2026

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”

Indeterminate GlobeNewswire, Inc.
Royalty Pharma Announces Dividend Increase
January 9, 2026

Royalty Pharma Announces Dividend Increase

Indeterminate GlobeNewswire, Inc.
iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger
January 9, 2026

iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger

Indeterminate GlobeNewswire, Inc.
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
January 9, 2026

Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation

Indeterminate GlobeNewswire, Inc.
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
January 9, 2026

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

Indeterminate GlobeNewswire, Inc.
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
January 9, 2026

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies

Indeterminate GlobeNewswire, Inc.
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
January 9, 2026

Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update

Indeterminate GlobeNewswire, Inc.
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
January 9, 2026

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

Indeterminate GlobeNewswire, Inc.
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
January 9, 2026

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

Indeterminate GlobeNewswire, Inc.
Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy
January 9, 2026

Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy

Indeterminate GlobeNewswire, Inc.
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain” 
January 9, 2026

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain” 

Indeterminate GlobeNewswire, Inc.
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
January 9, 2026

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Indeterminate GlobeNewswire, Inc.
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
January 9, 2026

O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated

Indeterminate GlobeNewswire, Inc.
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
January 9, 2026

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy

Indeterminate GlobeNewswire, Inc.
UM to establish five science and technology faculties through faculty restructuring
January 9, 2026

UM to establish five science and technology faculties through faculty restructuring

Gov't Institution Macao Government News
Owner: Macau Government

Macao Government News

Gov't Institution
Owned By Macau Government
Year Founded Indeterminate
Website www.gcs.gov.mo
Domain Registration Year Indeterminate
Access Type open
Publication Location Macao, Macao
Owner Country Macao

We welcome your feedback!
If you have comments or corrections, let us know.

Earth Harmony Ultimate Methylene Blue Addresses Consumer Demand for USP Pharmaceutical-Grade Verification in Mitochondrial Support Category
January 9, 2026

Earth Harmony Ultimate Methylene Blue Addresses Consumer Demand for USP Pharmaceutical-Grade Verification in Mitochondrial Support Category

Indeterminate GlobeNewswire, Inc.
WellSpan Health Announces Comprehensive Migration of Technology Portfolio to AWS
January 8, 2026

WellSpan Health Announces Comprehensive Migration of Technology Portfolio to AWS

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions